Fluciclovine F-18: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Fluciclovine F-18. Educational only — not medical advice.
Labeled uses
Axumin is indicated for positron emission tomography (PET) in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen (PSA) levels following prior treatment.
Source: FDA labeling via NIH DailyMed (set 389a502e…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.